Walgreens Boots Alliance, Inc. company logo

# 1st Gen Model Walgreens Boots Alliance, Inc. Drug stores & proprietary stores

Subscribe >> Deal exit on
Oct. 23, 2017
Deal entry on
Oct. 23, 2017
3.85%Expected margin
61.29% successful of 31 deals
$67.51 Last close price
at 23-oct-2017

WBA

Model's trade recommendations -10.71% Return for period

-3.55% Annual return

$72.83B Market Cap

β 1.25  

WBA

Model (following trade recommendations)

WBA

Underlying stock

S&P 500

Index
Return for period -10.71%
-14.63%
1.78%
52wk return -4.70%
-18.77%
16.82%
52wk Range
67.20—87.73
2000.54—2399.63
Sortino ratio -0.48
Sharpe ratio -0.44
Norm. RMSE 0.85%
Downside risk 7.46%
Volatility 8.12%
  • 1.60 (2.35%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.

Industry sector: Retail/Wholesale

Sector classification: Drug stores & proprietary stores

Deep Learning based analysis and prediction model for Walgreens Boots Alliance, Inc. (WBA) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for WBA model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 926M
P/E 14.00
Shares Outstanding 1070M
% Held by Insiders 13.50%
% Held by Institutions 60.19%
EPS (last reported FY) $4.59
EPS (last reported Q) $1.33
EPS, estimated (last reported Q) $1.31
Total revenues $117 B
Net income $4 B